Skip to main content
Wild Intelligence · The Frontier File Aggressive growth · Asymmetric upside · Zero corporate-speak
Issue № 012 · August 1, 2026 · Weekend Edition

Proof
Week.

Six portfolio companies report before next Monday. One jobs print can move the discount rate. And the least theatrical stock in my nuclear sleeve may have the cleanest chance to earn more weight.

One concentrated frontier-technology portfolio, documented in public
Day 123 · Ledger date: August 1, 2026 · Currency: USD
+69.0%
Latest reconciled gain
Through the July 13 published mark
$8,904
Latest reconciled book
From $5,270 starting capital
+$3,634
Dollar gain from start
At the latest full mark
21
Active positions
7 Core · 7 Growth · 6 Spec · 1 Moonshot
Performance Tracker

The climb, without pretending the ledger is cleaner than it is.

The portfolio began with $5,270. The latest fully reconciled published mark was $8,904, a gain of $3,634 or 69.0%.

Day 0
Starting capitalThe original line in the sand.
$5,270
Day 80
June 18 markThe book recovered from the first meaningful rate scare.
$7,860 · +49.1%
Day 104
July 13 markThe last complete published portfolio reconciliation.
$8,904 · +69.0%
Day 123
Current ledgerTwenty-one active positions, including the new $250 Microsoft starter. A fresh full-dollar mark awaits cash and brokerage reconciliation.
21 positions

The performance percentage remains anchored to the latest fully reconciled book value. I am not inventing an August 1 total while current cash and every brokerage mark remain unverified.

Cold Open

The frontier gets audited.

This is the week when a portfolio full of future tense has to start speaking in numbers.

BWXT reports Monday. SpaceX reports Tuesday. Aeva reports Wednesday. D-Wave and Serve report Thursday. MDA reports Friday. Archer and Rocket Lab follow next Monday.

Then Friday morning, the jobs report walks in and changes the discount rate underneath all of them.

That is the real Issue 12 story.

Not the new Microsoft fraction. Not a merger rumor. Not another shiny technology map.

Proof.

Revenue against promises. Backlog against valuation. Cash flow against capital needs. Milestones against calendars that have already moved once.

A catalyst is only useful when it tells me what to do after the headline.
New Position

Microsoft joined the Core. That is enough Microsoft for this issue.

Friday morning, I deployed exactly $250 at Microsoft’s $450.00 opening price, purchasing 0.5556 shares.

Microsoft closed at $464.72, marking the position at approximately $258.18—up $8.18, or 3.27%, on day one.

The trade is complete. It improves the portfolio’s cash-flow quality and adds another direct route from AI spending to enterprise revenue.

Action: Hold. No second Microsoft purchase this week.

One quality upgrade does not require an immediate sequel.
Company Focus

BWXT is the quiet position with the loudest opportunity.

BWXT reports Monday after the close, and it may be the most important decision point in the portfolio—not because one share can move the whole account, but because the company represents the direction I want the account to move.

Frontier exposure with receipts.

BWXT entered the quarter after reporting $860.2 million of first-quarter revenue, $91.2 million of net income and $148.0 million of adjusted EBITDA. Management raised its 2026 outlook to more than $3.75 billion of revenue, adjusted EBITDA of $650 million to $665 million, non-GAAP earnings of $4.60 to $4.75 per share and free cash flow of $315 million to $330 million.

Q1 Revenue
$860.2M
Operating scale today
Q1 Adjusted EBITDA
$148.0M
Not a concept-stage story
Backlog
$8.65B
Roughly 60% expected by end-2027
2026 FCF Guide
$315–330M
The number that funds expansion

The backlog was approximately $8.65 billion at the end of March, with roughly 60% expected to convert through the end of 2027. That visibility separates BWXT from the portfolio’s pre-revenue nuclear exposure.

Then came the Precision Components Group acquisition.

The deal adds more than 500,000 square feet of U.S. manufacturing capacity, over 450 employees and capabilities in large-envelope machining, heavy weldments, pressure vessels, heat exchangers and ASME-certified components.

That matters because the nuclear thesis is becoming a supply-chain thesis.

Reactors need fuel. They need forgings. They need qualified welds, pressure vessels, specialized machining and factories that cannot be recreated by adding “AI-powered” to a presentation.

BWXT is also carrying momentum from $1.4 billion of naval nuclear-propulsion contracts and progress in TRISO fuel production. The company touches naval reactors, advanced nuclear systems, medical isotopes, microreactors and space power.

That does not make the stock automatically cheap. It makes Monday’s report worth reading properly.

The six questions Monday must answer

Does management maintain or raise guidance?A clean quarter is not enough if the forward outlook slips.
Is backlog still growing with healthy economics?Backlog is only valuable when it converts at attractive margins.
What does Precision Components contribute?I want integration costs, revenue timing, margin expectations and capacity benefits—not acquisition poetry.
Is free-cash-flow conversion intact?BWXT earns Core status because it can finance expansion rather than repeatedly sell the dream.
Are naval and government programs still accelerating?These contracts provide the base that makes advanced-reactor optionality investable.
What is moving from optionality toward revenue?TRISO fuel, microreactors, nuclear medicine and space power need specific milestones.

What would make me add

I am prepared to add approximately $100 of BWXT after earnings when guidance is maintained or raised, backlog remains healthy and the stock does not gap more than roughly 5% above Friday’s close.

The better setup would be a 3% to 7% decline caused by integration expenses, timing or conservative commentary—provided the backlog, cash-flow outlook and long-term thesis remain intact.

No add after a material guidance cut, weakening backlog, margin deterioration or evidence that the acquisition is consuming more capital than expected.

BWXT does not need to become exciting. It needs to keep becoming important.
Thesis Board

Where my head is at.

Cash-Flow Infrastructure MSFT · GOOGL · AMZN · NVDA · BWXT
The portfolio’s strongest direction: companies that can finance their own growth and occupy hard-to-replicate infrastructure positions.
Memory and Storage MU · STX
The bottleneck thesis remains intact. Both positions are already right-sized after the Micron trim.
Space Stack SPCX · RKLB · PL · MDA · ASTS
This week separates operating proof from thematic excitement. No basket-level decision; every company gets graded separately.
Electric Aviation ACHR · JOBY
Archer needs a concentration rule. Joby remains the steadier counterweight. Certification still matters more than the tape.
Quantum and Physical AI QBTS · SERV · AEVA
All three face near-term proof tests. Small positions remain the correct positions until revenue and unit economics catch up.
Nuclear Optionality OKLO
Keep the dream small. BWXT is the operating nuclear position; Oklo is the asymmetric seasoning.
Current Portfolio

Twenty-one active positions. Four jobs.

Core · 7

MSFT 0.5556 · GOOGL 2 · NVDA 3 · MU 0.79 · STX 1 · BWXT 1 · AMZN 1

Growth · 7

ACHR 110 · JOBY 30 · RKLB 5 · PL 12 · MDA 9 · SOFI 10 · ASTS 2

Speculative · 6

SPCX 1 · CENX 5 · OKLO 2 · SERV 4.5 · AEVA 4 · INTC ≈0.965

Moonshot · 1

QBTS 16

Exited: ARM. Recent risk reductions: SERV cut from 9 shares to 4.5; MU cut from 1.58 shares to 0.79; SPCX previously reduced to 1 share.

Current cash: not fully reconciled. Any proceeds from a coming trade should remain cash until the catalyst wave clears.

Catalyst Calendar

What reports, what matters and what I plan to do.

Mon · Aug 3
BWXT earnings
After the close.
Guidance, backlog, margins, cash conversion and Precision Components integration.
Possible Add
Tue · Aug 4
SpaceX earnings
After the close.
Starlink economics, launch cadence, Starship spending and cash generation. JOLTS at 10:00 a.m. ET.
Hold 1
Wed · Aug 5
Aeva earnings
After the close.
Commercial nominations, production timing, industrial demand and liquidity.
No Add
Thu · Aug 6
D-Wave before open
Serve after close.
QBTS: bookings conversion and revenue. SERV: utilization, revenue per robot, cash burn and Diligent integration.
Double Binary
Fri · Aug 7
MDA Space earnings
Before the open.
Backlog, satellite margins, robotics demand and financing. July employment report at 8:30 a.m. ET.
Macro + Space
Mon · Aug 10
Archer and Rocket Lab
After the close.
ACHR: certification, production and cash. RKLB: Neutron, margins, backlog and Iridium financing.
Portfolio Heavy

The catalyst hierarchy

Most actionable: BWXT. The report can justify a quality addition.

Largest concentration decision: Archer. Price movement before earnings may create a trim opportunity.

Most important strategic update: Rocket Lab. The Iridium agreement changes both the upside and the balance-sheet risk.

Highest binary risk: D-Wave, Serve and Aeva. Small positions are already doing their job.

Largest macro swing factor: Friday’s jobs report. A hot number can lift yields and punish long-duration names even when company results are fine.

M&A Radar

Real transactions, not rescue fantasies.

BWXT + Precision Components Group Completed
Adds real domestic manufacturing capacity and skilled labor. Monday should clarify the near-term financial contribution.
Rocket Lab + Iridium Announced Agreement
Creates a broader end-to-end space platform. Also raises financing, integration and execution questions that earnings must address.
Serve + Diligent Robotics Completed
Expands Serve into hospitals. Thursday needs to show whether the combination broadens economics or merely broadens cash burn.

Everything else stays outside the thesis until a filing, formal announcement or credible report appears. A buyout is optional upside. It is not an investment process.

Two Potential Moves

One quality add. One concentration trim.

Recommendation 01

Add approximately $100 of BWXT—conditionally.

  • Wait for Monday’s report.
  • Require maintained or raised guidance.
  • Require healthy backlog and cash-flow conversion.
  • Do not chase a gap greater than roughly 5%.
  • Prefer a 3%–7% decline on temporary timing or integration noise with the thesis intact.

Invalidation: guidance cut, weakening backlog, margin deterioration or acquisition trouble.

Recommendation 02

Trim 10 ACHR shares on an unsupported spike.

Sell 10 shares only if Archer rallies at least roughly 8% before August 10 without a binding contract, meaningful FAA milestone, funded order or other thesis-changing evidence.

  • Reduce the position from 110 shares to 100.
  • Keep the proceeds as cash.
  • Do not rotate directly into another speculative name.
  • If the rally never arrives, hold and reassess after earnings.
The Hot Take
“The most important company next week may be the one least likely to trend on social media. That is not a bug. That may be the opportunity.”
Buddy, Real Talk

I do not need every catalyst to become a trade.

This portfolio has trained me to treat empty calendar space like a personal insult.

There is always another launch, filing, earnings call, certification update or company claiming the future has moved into its warehouse.

Next week offers enough action to make overtrading feel like research.

It is not.

The Microsoft trade is done. The speculative earnings positions are already sized. SpaceX is down to one share. Serve has already been cut in half. Micron has already been right-sized.

The only new money decision with a clean quality argument is BWXT—and even that decision waits for Monday’s evidence.

The Archer decision is not about abandoning the thesis. It is about refusing to let a large position get larger merely because the stock gets excited before the company reports.

This week, discipline will look less like finding the perfect stock and more like declining seven invitations to improvise.

The Bottom Line

The account has reached the part where proof matters more than possibility.

The latest fully reconciled tracker remains $8,904 from $5,270—a gain of $3,634, or 69.0%. The current ledger holds 21 positions across Core, Growth, Speculative and Moonshot tiers.

Microsoft added quality, but it is not the center of the week.

BWXT is the clearest potential upgrade. SpaceX must disclose the economics. Aeva, D-Wave and Serve must show commercial progress. MDA must convert backlog. Archer must show certification discipline. Rocket Lab must explain how a larger empire gets financed without weakening the launch business still under construction.

Friday’s jobs report can move all of them at once.

My plan is simple:

Hold Microsoft.

Let BWXT earn a $100 addition.

Use an unsupported Archer rally to reduce concentration.

Keep the binary names small.

Do not confuse a crowded calendar with a mandate to act.

The frontier remains open. Next week, it brings receipts.

See you next Sunday, buddy. — Alex

Source Notes

Receipts.

  1. Frontier File Issue 3 — $5,270 starting capital; $7,860 book value and +49.1% on Day 80.
  2. Frontier File Issue 9 — $8,904 book value and +69.0% on Day 104.
  3. Microsoft July 31, 2026 market data — $450.00 open and $464.72 close.
  4. Microsoft FY2026 fourth-quarter results.
  5. BWXT first-quarter 2026 results and raised guidance.
  6. BWXT first-quarter filing — backlog and expected conversion.
  7. BWXT completion of the Precision Components Group acquisition.
  8. BWXT August 3 earnings schedule.
  9. SpaceX August 4 earnings schedule.
  10. Aeva August 5 earnings schedule.
  11. D-Wave August 6 earnings schedule.
  12. Serve Robotics August 6 earnings schedule.
  13. MDA Space August 7 earnings schedule.
  14. Archer August 10 earnings schedule.
  15. Rocket Lab August 10 earnings schedule and company releases concerning Iridium.
  16. U.S. Bureau of Labor Statistics August 2026 release calendar.
§ Related reading
§ The frontier continues.

Get the next issue when it drops.

One sharp dispatch from the frontier: what changed, what matters, what I'm watching, what the evidence changed — and what the portfolio is doing about it.

No spam. No daily market sludge. Research notes only. Unsubscribe whenever.